Business support

Opportunities of Business Support

Stay up-to-date with human capital related developments in the LSH sector

200 million euros for SMEs

Read more ›

SME cluster of the Netherlands Enterprise Agency (RVO) supports Dutch SMEs with EU funding. 

Read more ›

Innovation Credit for technological R&D projects

Read more ›

Module Clinical Development of novel medical interventions

Read more ›

Bambi Medical during their dry-run of their pitch at RVO: from left to right:

Fabio Bambang Oetomo, Sidarto Bambang Oemoto, Emmie Steeghs

SME cluster of the Netherlands Enterprise Agency (RVO) supports Dutch SMEs with EU funding. 

For more information about the European subsidy programmes SME instrument, Fast Track to Innovation, Eurostars and GlobalStars, please visit:

https://www.rvo.nl/subsidies-regelingen/horizon-2020

https://www.rvo.nl/subsidies-regelingen/eurostars

https://ec.europa.eu/easme/en/sme-instrument

https://ec.europa.eu/easme/en/eic-fast-track-innovation-fti

https://www.rvo.nl/subsidies-regelingen/globalstars-stimulering-marktgerichte-rd-met-partners-buiten-europa


For more information about the services of the MKB cluster, please visit: https://www.rvo.nl/subsidies-regelingen/horizon-2020


Or contact Gwendolynn Bos-Grootaers, National Contact Point Horizon 2020 - SME Instrument.

Telephone: + 31 (0)6 112 744 79

Email: gwendolynn.grootaers@rvo.nl

Health~Holland and MedtechPartners introduce the Innovation Broker

Read more ›

Health~Holland and MedtechPartners introduce the Innovation Broker

Toolbox of LifeSciences@Work Accelerator expands SME guidance

The collaboration between the Top Sector Life Sciences & Health (LSH) with the MedtechPartners foundation aims to make medtech and biotech innovations faster available for patients and professionals. Within the LifeSciences@Work Accelerator MedtechPartners organises MedtechPartners and BiotechPartners meetings where expert knowledge is unlocked to entrepreneurs. This helps entrepreneurs to speed up their development and tackle their challenges. In addition to these meetings the Accelerator toolbox is expanded with the Innovation Broker.

The support of the Innovation Broker

Start-ups and SMEs can hire an Innovation Broker to get access to specialised consultative support. This extra guidance helps in building smart collaborations and co-creation partnerships in order to increase the development of new life sciences and health technologies.


Selection criteria for the entrepreneurs that want to make use of the Innovation Broker:

  • You already have pitched at the Venture Challenge, a MedtechPartners or BiotechPartners meeting
  • You want to collaborate with one or multiple partners
  • Your success rate to achieve the next Technology Readiness Level (TRL) level is higher than 50% in the next 24 months.


Want to know more about the Innovation Broker? Please contact Joep Welschen of MedtechPartners (j.welschen@kplusv.nl). Read more about the LifeSciences@Work Accelerator, MedtechPartners and BiotechPartners meetings.

Innovation Credit for technological R&D projects

With the innovation credit the Ministry of Economic Affairs and Climate Policy gives start-ups and SMEs financial support for risky innovation projects. By doing this the government fills the gap in the capital market in a phase where entrepreneurs are busy getting things going, but have not yet generated returns.

Innovation Credit in practice

Various entrepreneurs have already successfully applied for Innovation Credit. Robot Care Systems (RCS) developed the Lean Empowering Assistant (LEA) in 2013. This is a high-tech tool with motor wheels that gives the elderly practical support during walking and daily activities. See how the Innovation Credit helped Robot Care Systems develop LEA in the video below. Are you interested in reading the stories of other entrepreneurs who successfully applied for Innovation Credit? See how they used the funding to grow their business in these showcases.


Are you a start-up or SME and interested in the Innovation Credit? Visit RVO.nl for more information on the Innovation Credit and the application requirements.

video-play-button

The module Clinical Development at Paul Janssen Futurelab Leiden provides learning-by-doing training to ambitious-postgraduate biomedical researchers. During this program, you will further your career and increase your knowledge on the optimal development of novel medical interventions, using real
life cases. Ready to go on-campus?


Online

In this five-week online Futurelab course, you are introduced to the question-based method of clinical development. This approach, which is based on the so-called Real Options Theory, facilitates the rational and efficient design of a pathway for developing novel medical interventions. You will learn how to apply this approach; how to formulate key questions; and how how to optimally deal with risk and costs in development. It is possible to take this online course as a stand-alone course.

  • 5 weeks online course
  • Online exam

On-campus + online

This 4-day On-campus course includes the Online course. During this intensive program, you will dive head first into a myriad of advanced teaching cases based on real-world examples. Working in small groups with fellow participants, you will work on various assignments that are based on actual projects in which novel medical interventions were developed. This on-campus Futurelab course takes place in the beautiful Dutch city of Leiden, which is only a 20-minute train ride from Schiphol Airport and close to Amsterdam.

  • 5 weeks online course
  • Online exam
  • 4 day On-campus


On-campus Extended + online

This 9-day On-campus Extended course includes both the 4-day On-campus and the Online course. In this extended program, you will work with a mentor (a clinical expert) to develop your own clinical trial based on the brief pre-proposal that you submitted with your application. In addition, your mentor will guide you through the scientific and practical challenges associated with drafting a clinical trial application. This on-campus Futurelab course also takes place in Leiden.

  • 5 weeks online course
  • Online exam
  • 4 day On-campus
  • 5 day On-campus extended
  • Win a € 500.000 grant

For more information read the brochure or visit www.pauljanssenfuturelab.eu

video-play-button

200 million euros for SMEs

With the SME action plan, the Council of Ministers has agreed to the proposal of the State Secretary for Economic Affairs and Climate Policy (Mona Keijzer). Over the past few months, the state secretary undertook an ‘SME tour’ through the Netherlands and talked to entrepreneurs about their three biggest challenges: staff, digitalisation and funding. The SME action plan will enable small and medium-sized enterprises to tackle these challenges. The government has made 200 million euros available for this until 2021.

The money from the action plan will be spent on maintaining and intensifying the current regulations. Apart from the expansion of innovation instruments like the Innovatiekrediet, the MIT regulation and the SBIR programme, money will be made available for the SEED regulation, and there will be more attention for human capital. Furthermore, there will be a regulation for Thematic Technology Transfer to connect research institutions conducting excellent research on specific themes, so that knowledge utilisation is improved.


A strong entrepreneurial climate

The plans are in addition to the new funding institution Invest-NL that will be established next year. Invest-NL will serve as a flywheel for the continued growth of Life Sciences & Health (LSH) businesses in different phases of development. The SME action plan safeguards and enhances existing stimulation measures for SMEs. Invest-NL and the SME action plan will contribute to a well-conceived funding mix for businesses in the LSH sector. With these two initiatives, the government is realising the ambitions stated in the coalition agreement to strengthen the entrepreneurial climate in the Netherlands.


For more information about the SME action plan consult the official announcement: https://www.rijksoverheid.nl/actueel/nieuws/2018/06/29/200-miljoen-euro-voor-het-mkb


Source: Rijksoverheid and HollandBIO